ATE406919T1 - Verfahren zur herstellung von radiomarkierten platin-chemotherapeutischen mitteln - Google Patents
Verfahren zur herstellung von radiomarkierten platin-chemotherapeutischen mittelnInfo
- Publication number
- ATE406919T1 ATE406919T1 AT01913394T AT01913394T ATE406919T1 AT E406919 T1 ATE406919 T1 AT E406919T1 AT 01913394 T AT01913394 T AT 01913394T AT 01913394 T AT01913394 T AT 01913394T AT E406919 T1 ATE406919 T1 AT E406919T1
- Authority
- AT
- Austria
- Prior art keywords
- radiom
- producing
- chemotherapeutic agents
- platinum chemotherapeutic
- labeled
- Prior art date
Links
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 title abstract 9
- 229910052697 platinum Inorganic materials 0.000 title abstract 5
- 239000002246 antineoplastic agent Substances 0.000 title abstract 3
- 229940127089 cytotoxic agent Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- -1 platinum halide Chemical class 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229910001507 metal halide Inorganic materials 0.000 abstract 1
- 150000005309 metal halides Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Manufacture And Refinement Of Metals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ6411A AUPQ641100A0 (en) | 2000-03-23 | 2000-03-23 | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE406919T1 true ATE406919T1 (de) | 2008-09-15 |
Family
ID=3820508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01913394T ATE406919T1 (de) | 2000-03-23 | 2001-03-23 | Verfahren zur herstellung von radiomarkierten platin-chemotherapeutischen mitteln |
Country Status (8)
Country | Link |
---|---|
US (1) | US7108845B2 (de) |
EP (1) | EP1282631B1 (de) |
JP (1) | JP4954417B2 (de) |
AT (1) | ATE406919T1 (de) |
AU (2) | AUPQ641100A0 (de) |
DE (1) | DE60135646D1 (de) |
ES (1) | ES2313949T3 (de) |
WO (1) | WO2001070755A1 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030082102A1 (en) * | 2001-06-25 | 2003-05-01 | Court Wayne S. | Radioactive platinum complexes for cancer treatment |
US6751280B2 (en) | 2002-08-12 | 2004-06-15 | Ut-Battelle, Llc | Method of preparing high specific activity platinum-195m |
CZ296459B6 (cs) * | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
US7526058B2 (en) * | 2004-12-03 | 2009-04-28 | General Electric Company | Rod assembly for nuclear reactors |
US8953731B2 (en) | 2004-12-03 | 2015-02-10 | General Electric Company | Method of producing isotopes in power nuclear reactors |
US8842800B2 (en) * | 2007-11-28 | 2014-09-23 | Ge-Hitachi Nuclear Energy Americas Llc | Fuel rod designs using internal spacer element and methods of using the same |
US9202598B2 (en) * | 2007-11-28 | 2015-12-01 | Ge-Hitachi Nuclear Energy Americas Llc | Fail-free fuel bundle assembly |
US20090135990A1 (en) * | 2007-11-28 | 2009-05-28 | Ge-Hitachi Nuclear Energy Americas Llc | Placement of target rods in BWR bundle |
US9362009B2 (en) * | 2007-11-28 | 2016-06-07 | Ge-Hitachi Nuclear Energy Americas Llc | Cross-section reducing isotope system |
US20090135989A1 (en) * | 2007-11-28 | 2009-05-28 | Ge-Hitachi Nuclear Energy Americas Llc | Segmented fuel rod bundle designs using fixed spacer plates |
US8437443B2 (en) | 2008-02-21 | 2013-05-07 | Ge-Hitachi Nuclear Energy Americas Llc | Apparatuses and methods for production of radioisotopes in nuclear reactor instrumentation tubes |
US8712000B2 (en) | 2007-12-13 | 2014-04-29 | Global Nuclear Fuel—Americas, LLC | Tranverse in-core probe monitoring and calibration device for nuclear power plants, and method thereof |
US8885791B2 (en) | 2007-12-18 | 2014-11-11 | Ge-Hitachi Nuclear Energy Americas Llc | Fuel rods having irradiation target end pieces |
US8180014B2 (en) * | 2007-12-20 | 2012-05-15 | Global Nuclear Fuel-Americas, Llc | Tiered tie plates and fuel bundles using the same |
US7970095B2 (en) * | 2008-04-03 | 2011-06-28 | GE - Hitachi Nuclear Energy Americas LLC | Radioisotope production structures, fuel assemblies having the same, and methods of using the same |
US8270555B2 (en) * | 2008-05-01 | 2012-09-18 | Ge-Hitachi Nuclear Energy Americas Llc | Systems and methods for storage and processing of radioisotopes |
US8050377B2 (en) | 2008-05-01 | 2011-11-01 | Ge-Hitachi Nuclear Energy Americas Llc | Irradiation target retention systems, fuel assemblies having the same, and methods of using the same |
US7781637B2 (en) * | 2008-07-30 | 2010-08-24 | Ge-Hitachi Nuclear Energy Americas Llc | Segmented waste rods for handling nuclear waste and methods of using and fabricating the same |
US8699651B2 (en) * | 2009-04-15 | 2014-04-15 | Ge-Hitachi Nuclear Energy Americas Llc | Method and system for simultaneous irradiation and elution capsule |
US9165691B2 (en) * | 2009-04-17 | 2015-10-20 | Ge-Hitachi Nuclear Energy Americas Llc | Burnable poison materials and apparatuses for nuclear reactors and methods of using the same |
US9431138B2 (en) * | 2009-07-10 | 2016-08-30 | Ge-Hitachi Nuclear Energy Americas, Llc | Method of generating specified activities within a target holding device |
US8366088B2 (en) * | 2009-07-10 | 2013-02-05 | Ge-Hitachi Nuclear Energy Americas Llc | Brachytherapy and radiography target holding device |
US8638899B2 (en) * | 2009-07-15 | 2014-01-28 | Ge-Hitachi Nuclear Energy Americas Llc | Methods and apparatuses for producing isotopes in nuclear fuel assembly water rods |
US8488733B2 (en) * | 2009-08-25 | 2013-07-16 | Ge-Hitachi Nuclear Energy Americas Llc | Irradiation target retention assemblies for isotope delivery systems |
US9773577B2 (en) * | 2009-08-25 | 2017-09-26 | Ge-Hitachi Nuclear Energy Americas Llc | Irradiation targets for isotope delivery systems |
US9183959B2 (en) * | 2009-08-25 | 2015-11-10 | Ge-Hitachi Nuclear Energy Americas Llc | Cable driven isotope delivery system |
US8542789B2 (en) * | 2010-03-05 | 2013-09-24 | Ge-Hitachi Nuclear Energy Americas Llc | Irradiation target positioning devices and methods of using the same |
US9899107B2 (en) | 2010-09-10 | 2018-02-20 | Ge-Hitachi Nuclear Energy Americas Llc | Rod assembly for nuclear reactors |
CA2986136A1 (en) | 2015-05-18 | 2016-11-24 | Syn-Nat Products Enterprise LLC | A pharmaceutical co-crystal and use thereof |
WO2016205785A1 (en) | 2015-06-19 | 2016-12-22 | Syn-Nat Products Enterprise LLC | Pharmaceutical composition of carboplatin based co-crystals and use thereof |
JP2018517759A (ja) | 2015-06-19 | 2018-07-05 | シン−ナット プロダクツ エンタープライズ エルエルシー | カルボプラチンを含む組成物及び用途 |
WO2016210418A1 (en) | 2015-06-25 | 2016-12-29 | Syn-Nat Products Enterprise LLC | Pharmaceutical co-crystal composition and use thereof |
MX2018006953A (es) | 2015-12-09 | 2019-05-16 | Univ Wien Med | Compuestos de platino funcionalizados con monomaleimida para la terapia del cancer. |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4177263A (en) * | 1972-02-28 | 1979-12-04 | Research Corporation | Anti-animal tumor method |
US5562925A (en) * | 1970-04-20 | 1996-10-08 | Research Corporation Tech. Inc. | Anti-tumor method |
US4339437A (en) * | 1976-12-27 | 1982-07-13 | Research Corporation | Anti-tumor method |
US4203912A (en) * | 1977-10-19 | 1980-05-20 | Johnson, Matthey & Co., Limited | Compositions containing platinum |
US4310515A (en) * | 1978-05-30 | 1982-01-12 | Bristol-Myers Company | Pharmaceutical compositions of cisplatin |
US4302446A (en) * | 1979-10-02 | 1981-11-24 | Bristol-Myers Company | Pharmaceutical compositions |
US4451447A (en) * | 1980-03-31 | 1984-05-29 | Bristol-Myers Company | Pharmaceutical formulations |
AU541056B2 (en) | 1980-03-31 | 1984-12-13 | Bristol-Myers Company | Pharmaceuticals formulations |
JPS6087295A (ja) * | 1983-10-19 | 1985-05-16 | Nippon Kayaku Co Ltd | 新規白金錯体 |
US4562275A (en) * | 1984-03-23 | 1985-12-31 | Bristol-Myers Co. | Antitumor platinum complexes |
GB8416048D0 (en) * | 1984-06-22 | 1984-07-25 | Johnson Matthey Plc | Anti-tumour compounds of platinum |
DK500185A (da) * | 1984-11-02 | 1986-05-03 | Johnson Matthey Plc | Oploeseliggjort platinforbindelse |
US4739087A (en) * | 1985-01-10 | 1988-04-19 | Bristol-Myers Company | Antineoplastic platinum complexes |
CA1275922C (en) * | 1985-11-28 | 1990-11-06 | Harunobu Amagase | Treatment of cancer |
AU605512B2 (en) * | 1986-10-07 | 1991-01-17 | Boehringer Mannheim Italia S.P.A. | Pharmaceutical compositions having antineoplastic activity |
JPH0714865B2 (ja) * | 1986-10-28 | 1995-02-22 | 武田薬品工業株式会社 | リポソ−ム製剤およびその製造法 |
US4943428A (en) * | 1987-07-10 | 1990-07-24 | Wright State University | Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents |
JPH01156990A (ja) * | 1987-09-26 | 1989-06-20 | Ajinomoto Co Inc | 新規白金錯体及びその用途 |
US5072011A (en) * | 1988-02-02 | 1991-12-10 | Johnson Matthey, Inc. | Pt(IV) complexes |
US5244919A (en) * | 1988-02-02 | 1993-09-14 | Johnson Matthey, Inc. | Pt(IV) complexes as anti-tumor agents |
GB8806224D0 (en) * | 1988-03-16 | 1988-04-13 | Johnson Matthey Plc | Platinum chemotherapeutic product |
GB8810173D0 (en) * | 1988-04-29 | 1988-06-02 | Norsk Hydro As | Pharmaceutical compositions with anti-cancer activity & method for treatment of cancer |
DE3827974A1 (de) * | 1988-08-18 | 1990-02-22 | Boehringer Mannheim Gmbh | Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen |
US5434256A (en) * | 1988-11-22 | 1995-07-18 | Board Of Regents, The University Of Texas System | Diamine platinum complexes as antitumor agents |
US5393909A (en) * | 1988-11-22 | 1995-02-28 | Board Of Regents, The University Of Texas System | Diamine platinum complexes as antitumor agents |
US4946689A (en) * | 1988-11-23 | 1990-08-07 | Bristol-Myers Company | Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin |
NL8901433A (nl) * | 1989-06-06 | 1991-01-02 | Pharmachemie Bv | Carboplatinpreparaat. |
US5158760A (en) * | 1990-05-30 | 1992-10-27 | Board Of Regents, The University Of Texas System | 99m TC labeled liposomes |
US5143713A (en) * | 1990-05-30 | 1992-09-01 | Board Of Regents, The University Of Texas System | 99m Tc labeled liposomes |
US5272056A (en) * | 1991-01-03 | 1993-12-21 | The Research Foundation Of State University Of New York | Modification of DNA and oligonucleotides using metal complexes of polyaza ligands |
US5434046A (en) * | 1991-03-01 | 1995-07-18 | The Regents Of The University Of California | Diagnostic assay based on cis-plain drug resistance gene |
GB9105037D0 (en) * | 1991-03-09 | 1991-04-24 | Johnson Matthey Plc | Improvements in chemical compounds |
WO1993008839A1 (en) * | 1991-11-08 | 1993-05-13 | Curators Of The University Of Missouri | Multifunctional ligands for potential use in the design of therapeutic or diagnostic radiopharmaceutical imaging agents |
US5696131A (en) * | 1993-01-22 | 1997-12-09 | Xenova Limited | Treatment of cancers |
US5455270A (en) * | 1993-08-11 | 1995-10-03 | Bristol-Myers Squibb Co. | Stabilized solutions of platinum(II) antitumor agents |
US5484612A (en) * | 1993-09-22 | 1996-01-16 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin |
US5635493A (en) * | 1993-12-01 | 1997-06-03 | Marine Polymer Technologies, Inc. | Methods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeutics |
GB9502799D0 (en) * | 1995-02-14 | 1995-04-05 | Johnson Matthey Plc | Improvements in platinum complexes |
US6008395A (en) * | 1995-02-28 | 1999-12-28 | Kidani; Yoshinori | Platinum (IV) complex, production process thereof and carcinostatic agent containing the same |
US6074626A (en) * | 1998-03-20 | 2000-06-13 | Molecular Radiation Management, Inc. | Radioactive cisplatin in the treatment of cancer |
-
2000
- 2000-03-23 AU AUPQ6411A patent/AUPQ641100A0/en not_active Abandoned
-
2001
- 2001-03-23 WO PCT/AU2001/000320 patent/WO2001070755A1/en active IP Right Grant
- 2001-03-23 AT AT01913394T patent/ATE406919T1/de not_active IP Right Cessation
- 2001-03-23 EP EP01913394A patent/EP1282631B1/de not_active Expired - Lifetime
- 2001-03-23 AU AU3902401A patent/AU3902401A/xx active Pending
- 2001-03-23 US US10/239,363 patent/US7108845B2/en not_active Expired - Lifetime
- 2001-03-23 JP JP2001568956A patent/JP4954417B2/ja not_active Expired - Fee Related
- 2001-03-23 DE DE60135646T patent/DE60135646D1/de not_active Expired - Lifetime
- 2001-03-23 ES ES01913394T patent/ES2313949T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1282631A4 (de) | 2005-02-09 |
US7108845B2 (en) | 2006-09-19 |
JP2003528108A (ja) | 2003-09-24 |
DE60135646D1 (de) | 2008-10-16 |
JP4954417B2 (ja) | 2012-06-13 |
AU3902401A (en) | 2001-10-03 |
WO2001070755A1 (en) | 2001-09-27 |
EP1282631B1 (de) | 2008-09-03 |
US20030103896A1 (en) | 2003-06-05 |
EP1282631A1 (de) | 2003-02-12 |
ES2313949T3 (es) | 2009-03-16 |
AUPQ641100A0 (en) | 2000-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE406919T1 (de) | Verfahren zur herstellung von radiomarkierten platin-chemotherapeutischen mitteln | |
DE69702037D1 (de) | Herstellung von hohlen Gussstücken aus thixotropen Metall-Legierungen unter Verwendung von Gasdruck | |
IL161498A0 (en) | Measurement of protein synthesis rates in humans and experimental system by use of isotopically labeled water | |
ATE291841T1 (de) | Puder für die kontrollierte freisetzung eines gases | |
DE69630949D1 (de) | Herstellung von vorbeschichteten aluminiumlegierungsteilen | |
DE69835357D1 (de) | Verfahren zur Herstellung von Synthesegas | |
ATE237008T1 (de) | Verfahren zur elektrolytischen herstellung von metallen | |
DE60041984D1 (de) | Basisches metallnitrat, verfahren zur herstellung | |
DE60100405D1 (de) | Verfahren zur Herstellung von Legierungspulvern | |
DE69835383D1 (de) | Hydrodynamisches Gaslager und Verfahren zu dessen Herstellung | |
ATE352036T1 (de) | Verfahren zur hochdurchsatzprofilierung neuer werkstoffe | |
DE60123509D1 (de) | Verfahren zur Herstellung von leichten Iso-Paraffinen aus Synthesegas | |
ID25465A (id) | Metode pembentukan film penginhibisi korosi dengan turunan benzotriazo terhidrogenasi | |
TR200001333T2 (tr) | Kiral amin oksazolinil ligandlara dayanan geçiş metali katalizlenmiş tepkimeler | |
DE69823662D1 (de) | 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen | |
ATE221026T1 (de) | Gaskarburierungsverfahren zur herstellung von reinem wc-pulver | |
DE69809055D1 (de) | Verfahren zur herstellung von reinem cis-tramadol | |
ATE337796T1 (de) | Verfahren zur herstellung von hyperpolarisiertem 129xe | |
DE69912827T2 (de) | "ligand presenting assembly" (lpa), verfahren zu dessen herstellung und verwendungen | |
DE69821903D1 (de) | Oxidationsmittel von mehreren Komponenten und Verfahren für eine dauerhafte Haarverformung durch die Verwendung desselben | |
ATE267799T1 (de) | Ein verfahren zur herstellung von (2s,2'r,3'r)-2- (2,3-dicarboxycyclopropyl)-glycin | |
DK0970467T3 (da) | Fremgangsmåde til talesyntese | |
DE69711592D1 (de) | Verfahren zur herstellung von synthesegas | |
ATE258202T1 (de) | Verfahren zur herstellung von hochreine, verzweigte, flüssige phenylsiloxane | |
DE50112449D1 (de) | Verfahren zur herstellung von 3,3-diarylpropylaminen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |